| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019905633 |
| P356 | DOI | 10.1186/1475-2875-10-250 |
| P932 | PMC publication ID | 3177816 |
| P698 | PubMed publication ID | 21867552 |
| P5875 | ResearchGate publication ID | 51595794 |
| P50 | author | Dominic P. Kwiatkowski | Q27664356 |
| Kirk A. Rockett | Q28028654 | ||
| Abdoulaye A. Djimde | Q28913759 | ||
| Issaka Zongo | Q28913761 | ||
| Jean-Bosco Ouedraogo | Q28913762 | ||
| Anna Jeffreys | Q56787541 | ||
| Eric Akum Achidi | Q56797838 | ||
| Kate Rowlands | Q96200536 | ||
| Rachel Craik | Q114069752 | ||
| Mahamadou Diakite | Q56776870 | ||
| Christina Hubbart | Q56787524 | ||
| Lisa C Ranford-Cartwright | Q37382963 | ||
| Wilfred Fomban Mbacham | Q44156522 | ||
| P2093 | author name string | Francis Kimani | |
| Mamadou M Tekete | |||
| Marie-Solange B Evehe | |||
| Angie Green | |||
| Baldip K Khan | |||
| Muntasir Ibrahim | |||
| Nawal Tagelsir | |||
| Olivia Achonduh | |||
| Sabah Omar Jezan | |||
| P2860 | cites work | How malaria has affected the human genome and what human genetics can teach us about malaria | Q21032480 |
| Candidate malaria susceptibility/protective SNPs in hospital and population-based studies: the effect of sub-structuring | Q21034139 | ||
| Activities of IRF-1 | Q24292304 | ||
| A membrane protein required for dislocation of misfolded proteins from the ER | Q24297703 | ||
| A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol | Q24297732 | ||
| Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation | Q24302539 | ||
| Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system | Q24305003 | ||
| Acquired immunity to malaria | Q24651173 | ||
| The International HapMap Project | Q27860695 | ||
| ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway | Q27932376 | ||
| Genetics of susceptibility to Plasmodium falciparum: from classical malaria resistance genes towards genome-wide association studies | Q28242298 | ||
| Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance | Q29615118 | ||
| High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: practice, problems and promise | Q30663683 | ||
| Single-nucleotide polymorphism analysis by MALDI-TOF mass spectrometry | Q30835412 | ||
| IRF-1Gene Variations Influence IgE Regulation and Atopy | Q57197961 | ||
| The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction | Q77419252 | ||
| Increased efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria among children with sickle cell trait in Western Kenya | Q44226634 | ||
| IL-4 inhibits macrophage-mediated killing of Plasmodium falciparum in vitro. A possible parasite-immune evasion mechanism | Q44762307 | ||
| Plasmodium falciparum: evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of sulfadoxine-pyrimethamine treatment of uncomplicated malaria | Q46224345 | ||
| In vivo efficacy study of quinine sulphate in the treatment of uncomplicated P. falciparum malaria in patients from Southwestern Cameroon | Q46668767 | ||
| Seroepidemiologic studies of humoral immune response to the Plasmodium falciparum antigens in Thailand | Q47855638 | ||
| Socio-economic and environmental protective/risk factors for severe malaria in Thailand | Q47879088 | ||
| Helminth infections are associated with protection from malaria-related acute renal failure and jaundice in Thailand. | Q47897726 | ||
| Critical comparison of molecular genotyping methods for detection of drug-resistant Plasmodium falciparum | Q47919280 | ||
| Cytoadherence of Plasmodium falciparum-Infected Erythrocytes to Microvascular Endothelium Is Regulatable by Cytokines and Phorbol Ester | Q48002470 | ||
| Putative pathophysiological interactions of cytokines and phagocytic cells in severe human falciparum malaria | Q48009928 | ||
| A molecular marker for chloroquine-resistant falciparum malaria | Q31921233 | ||
| High level multiplex genotyping by MALDI-TOF mass spectrometry | Q31954159 | ||
| Age-dependent acquired protection against Plasmodium falciparum in people having two years exposure to hyperendemic malaria | Q33356958 | ||
| Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy | Q33702580 | ||
| Reciprocal regulation of Th1- and Th2-cytokine-producing T cells during clearance of parasitemia in Plasmodium falciparum malaria. | Q33770311 | ||
| The immunology of malaria infection | Q33970972 | ||
| Pharmacogenetics of antimalarial drugs: effect on metabolism and transport | Q34020238 | ||
| Interferon regulatory factor-1 polymorphisms are associated with the control of Plasmodium falciparum infection | Q34239821 | ||
| A genetic association study in the Gambia using tagging polymorphisms in the major histocompatibility complex class III region implicates a HLA-B associated transcript 2 polymorphism in severe malaria susceptibility | Q34352459 | ||
| Multiple tests for genetic effects in association studies. | Q34559329 | ||
| A molecular map of chloroquine resistance in Mali | Q34630382 | ||
| Population genetics and dynamics of Plasmodium falciparum: an ecological view | Q36127068 | ||
| Different response to Plasmodium falciparum malaria in west African sympatric ethnic groups | Q36689861 | ||
| Whole genome amplification from a single cell: implications for genetic analysis | Q37081188 | ||
| Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma | Q37360189 | ||
| Genome-wide comparisons of variation in linkage disequilibrium | Q37395196 | ||
| Host immunity as a determinant of treatment outcome in Plasmodium falciparum malaria | Q37686622 | ||
| NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity. | Q38315256 | ||
| The impact of age, temperature, and parasite density on treatment outcomes from antimalarial clinical trials in Kampala, Uganda. | Q38881480 | ||
| Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda | Q38885315 | ||
| Influence of hemoglobin E trait on the antimalarial effect of artemisinin derivatives | Q39089908 | ||
| Clinical status and implications of antimalarial drug resistance. | Q39122722 | ||
| Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children | Q39195300 | ||
| Contribution of humoral immunity to the therapeutic response in falciparum malaria | Q39229106 | ||
| Evidence for a reduced effect of chloroquine against Plasmodium falciparum in alpha-thalassaemic children | Q39257187 | ||
| Antimalarial drugs clear resistant parasites from partially immune hosts | Q39478595 | ||
| Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to plasmodium falciparum malaria | Q40585807 | ||
| Host factors affecting the delay of reappearance of Plasmodium falciparum after radical treatment among a semi-immune population exposed to intense perennial transmission | Q40621412 | ||
| Genetic susceptibility to malaria and other infectious diseases: from the MHC to the whole genome | Q41018500 | ||
| Identification of a Stat-6-responsive element in the promoter of the human interleukin-4 gene | Q41096033 | ||
| Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. | Q41914794 | ||
| Chloroquine and sulphadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso, Burkina Faso during a 3-year period 1998-2000. | Q41916761 | ||
| Chloroquine treatment for uncomplicated childhood malaria in an area with drug resistance: early treatment failure aggravates anaemia | Q41924982 | ||
| Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins | Q41927581 | ||
| High frequency of Plasmodium falciparum PfCRT K76T and PfpghN86Y in patients clearing infection after chloroquine treatment in the Sudan. | Q41946767 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| P304 | page(s) | 250 | |
| P577 | publication date | 2011-08-25 | |
| P1433 | published in | Malaria Journal | Q15749954 |
| P1476 | title | Host candidate gene polymorphisms and clearance of drug-resistant Plasmodium falciparum parasites | |
| P478 | volume | 10 |
| Q33698822 | Geographical distribution of complement receptor type 1 variants and their associated disease risk | cites work | P2860 |
Search more.